Immunotherapy for Cancer Treatment in Delhi
Cancer treatment has significantly evolved over the past decade, and immunotherapy for cancer treatment in Delhi has emerged as one of the most promising advances in modern oncology. Unlike traditional treatments that directly attack cancer cells, immunotherapy works through your own immune system to identify and destroy cancer, offering renewed hope for patients with many types of cancer.
Delhi, as India’s premier medical hub, is now home to world-class oncologists and cutting-edge cancer care centres offering immunotherapy for cancer across all major specialties. Whether you are seeking a second opinion or exploring advanced treatment after conventional therapies, immunotherapy may be the breakthrough your care plan needs.
This page provides a complete guide to understanding immunotherapy treatment – what it is, how it works, who qualifies, what it costs in Delhi, and why choosing an experienced specialist matters.
Reach Out for Expert Care
What is Immunotherapy for Cancer?
Immunotherapy for cancer is a type of biological therapy that stimulates or restores the body’s natural immune defences to detect and fight cancer cells. The immune system typically identifies and eliminates abnormal cells, but cancer cells can develop ways to evade this defence. Cancer immunotherapy works by removing these escape mechanisms or by boosting the immune system’s ability to recognise and attack tumours.
Unlike chemotherapy, which indiscriminately kills rapidly dividing cells, immunotherapy treatment is more targeted. It teaches the immune system to distinguish cancer from healthy tissue, resulting in a more precise therapeutic action.
Types of Immunotherapy
Several types of immunotherapy for cancer are available, each working in a different way to help the immune system fight cancer:
- Checkpoint Inhibitors: Block “off signals” (PD-1, PD-L1, CTLA-4), allowing immune cells to attack cancer more effectively.
- CAR T-Cell Therapy: Patient’s immune cells are modified in a lab to recognise better and destroy cancer cells; mainly used in blood cancers.
- Monoclonal Antibodies: Target specific proteins on cancer cells, helping the immune system identify and eliminate them or block tumour growth.
- Cancer Vaccines: Stimulate the immune system to recognise and attack cancer cells after diagnosis.
- Other Immunotherapies: Include cytokines (boost immune activity), oncolytic viruses (destroy cancer cells), and BCG therapy (used in bladder cancer).
Immunotherapy strengthens the immune system to detect and attack cancer cells more effectively and helps prevent the disease from returning over time.
What Types of Cancer Can Be Treated with Immunotherapy?
Immunotherapy has received regulatory approval for a growing number of cancers. In Delhi’s leading oncology centres, it is commonly used for:
- Lung cancer (non-small cell lung cancer, NSCLC) checkpoint inhibitors are the standard of care
- Melanoma
- Breast cancer, particularly triple-negative breast cancer (TNBC)
- Colorectal cancer, especially MSI-high or mismatch repair-deficient tumours
- Bladder cancer, BCG therapy
- Head and neck cancers
- liver cancer
- kidney cancer
- Lymphomas and leukaemias, especially with CAR T-cell therapy
Your oncologist will evaluate your tumour to determine whether immunotherapy is appropriate for your specific cancer.
Immunotherapy Procedure Overview
The immunotherapy procedure depends on treatment type, but for the most common forms, the general process is:
- Comprehensive Evaluation: Blood tests, imaging (PET/CT scan), biopsy, and biomarker testing.
- Treatment Planning: Your oncologist selects the appropriate immunotherapy drug and protocol based on your cancer profile.
- Pre-treatment Baseline: Organ function tests, ECG, and baseline immune function assessment.
- Infusion: Most immunotherapy drugs are given as intravenous (IV) infusions at an oncology day care centre. Sessions typically last 30 minutes to 2 hours.
- Monitoring During Treatment: Regular blood tests, imaging, and clinical assessment to monitor response and detect side effects.
- Response Evaluation: Restaging scans (usually every 2–3 months) to assess tumour response.
- Continuation or Adjustment: Based on response, treatment may be continued, escalated, or switched to an alternative approach.
Benefits of Immunotherapy
Immunotherapy offers a promising approach to cancer treatment by enhancing the body’s natural defences.
- Durable Responses: Can provide long-lasting cancer control, even after treatment ends.
- Targeted Action: Specifically attacks cancer cells while minimising damage to healthy tissues.
- Broad Applicability: Effective across multiple cancer types and stages.
- Immune Memory: Helps the immune system remember and respond to cancer if it returns.
- Better Quality of Life: Generally better tolerated than chemotherapy, allowing patients to maintain daily activities.
These are the key benefits of immunotherapy, highlighting its effectiveness, precision, and patient-friendly approach.
Latest Advances in Immunotherapy
Recent advances in immunotherapy are making cancer treatment more effective and personalised. CAR T-cell therapy is now being studied for solid tumours, expanding its use beyond blood cancers. Personalised cancer vaccines, including mRNA-based therapies, are showing promising early results by targeting individual tumour mutations.
Risks and Side Effects of Immunotherapy
While immunotherapy side effects differ from those of chemotherapy, they are not absent. It can sometimes cause inflammation in healthy tissues, and side effects can be:
- Fatigue
- Skin reactions: Rash, itching
- Gastrointestinal effects: Diarrhoea, colitis
- Endocrine disruption: Thyroid dysfunction, adrenal insufficiency, or diabetes
- Pulmonary inflammation (pneumonitis): Less common but potentially serious
Most immunotherapy side effects are manageable with corticosteroids or other immunosuppressants when detected early. This is why regular monitoring by an experienced immunotherapy specialist in Delhi is critical throughout treatment.
Immunotherapy Cancer Treatment Cost in Delhi
Immunotherapy cost in Delhi depends on the drug type, number of cycles, cancer type and stage, diagnostic tests, and insurance coverage. Here is what patients typically need to plan for:
| Treatment Type | Approximate Cost per Cycle (INR) |
| Checkpoint Inhibitors (e.g., Pembrolizumab, Nivolumab) | ₹1,50,000 – ₹3,50,000 per infusion |
| Monoclonal Antibodies (e.g., Trastuzumab, Rituximab) | ₹40,000 – ₹1,50,000 per cycle |
| CAR T-Cell Therapy | ₹20,00,000 – ₹40,00,000+ (one-time) |
| Cancer Vaccines | ₹30,000 – ₹80,000 per dose |
Need clarity on immunotherapy costs and treatment options?
Consult Dr. Satyendra Katewa for a personalised assessment and transparent cost estimate tailored to your condition.
Why Choose Dr. Satyendra Katewa for Immunotherapy Cancer Treatment in Delhi
Patients searching for an immunotherapy specialist in Delhi or a cancer immunotherapy expert in Delhi can expect the following under Dr. Katewa’s care:
- Comprehensive diagnostic assessment to evaluate suitability for immunotherapy-based cancer treatment
- Evidence-based immunotherapy protocols aligned with current oncology guidelines
- Personalised treatment planning for early-stage, advanced, and recurrent cancers
- Dedicated experience in immunotherapy treatment for both adult and paediatric cancer patients in Delhi
- Regular monitoring of treatment response and immune-related side effects throughout the care journey
All treatment decisions are based on individual clinical assessment and tumour profile.
Final Thoughts
If you or a loved one has received a cancer diagnosis or is exploring targeted treatment immunotherapy options beyond chemotherapy, a specialist evaluation is strongly recommended.
Scheduling a consultation with Dr. Satyendra Katewa can help determine whether immunotherapy is the right approach for your condition and guide a personalised cancer treatment plan in Delhi.
Dr. Satyendra Katewa's Medical Content Team
Dr. Satyendra Katewa’s medical content team specialises in developing accurate, evidence-based, and patient-focused healthcare content. With strong clinical insight and expertise in medical writing and SEO, the team simplifies complex haematology and oncology information into clear, trustworthy resources that support informed decision-making and reflect Dr. Katewa’s commitment to ethical, compassionate care.
This content is reviewed by Dr. Satyendra Katewa
Related Blogs
Best Treatment Options for Leukaemia in Children
Leukaemia is the most common cancer affecting children. If your child has been diagnosed with…
Read Article →
Recovery After Bone Marrow Transplant in Children
A bone marrow transplant (BMT) is a life-saving treatment for many childhood cancers and blood…
Read Article →
Early Signs of Blood Cancer in Children: What Every Parent Should Know
Seeing your child unwell can make any parent anxious. Most childhood illnesses, such as fever,…
Read Article →